©2026 Incunabulum LLC. All rights reserved. mg Magazine is a registered trademark of Incunabulum LLC. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with prior written permission.
Tag: Fragile X syndrome
Pharmaceutical Company Develops Synthetic Cannabinoid Treatments
Pennsylvania-based Zynerba Pharmaceuticals is currently developing synthetic cannabinoid treatments, which were featured this week in the U.K.’s Daily Mail. Human trials are being conducted...